Explore Canada’s New Drug Submission (NDS) and Abbreviated New Drug Submission (ANDS) processes. Learn about drug submission guidelines, regulatory compliance, manufacturing standards, and the approval process by Health Canada. We provide expert regulatory services for New Drug Submissions (NDS) and Abbreviated New Drug Submissions (ANDS) in Canada. We are your company’s trusted partner in navigating the intricate regulatory landscape to bring your pharmaceutical products to market efficiently and compliantly. Don’t let regulatory hurdles hinder your path to market—partner with Quality Smart Solutions for efficient, compliant, and successful SANDS and ANDS submissions.
Drug Submission Preparation
We meticulously prepare your NDS and ANDS, ensuring that all required documentation is complete and accurate. Our attention to detail minimizes potential delays in the approval process.
Regulatory Compliance
We guide you through the complex landscape of regulatory compliance. From labeling requirements to safety assessments, we ensure your submissions are fully compliant.
Quality Control
Our team is committed to maintaining the highest quality standards for your pharmaceutical products. We guide quality control processes and procedures.
Approval Strategy
We develop a tailored approval strategy that aligns with your business goals. Our approach maximizes the chances of a successful submission.
Ongoing Support
Our support doesn’t end with submission. We provide ongoing assistance, ensuring your products remain compliant throughout their lifecycle.
Here’s how DIN numbers matter for NDS:
DIN numbers are a critical component of the NDS process in Canada. They are essential for product identification, regulatory compliance, safety monitoring, and marketing. When preparing an NDS, ensuring that your proposed drug product has a unique DIN is a fundamental step in obtaining approval for its sale in the Canadian market.
Regulatory Proficiency: Regulatory experts possess a profound understanding of the ever-evolving regulations governing pharmaceuticals. They stay abreast of the latest changes, ensuring your submissions align seamlessly with current standards.
Accelerated Approvals: With their experience, regulatory experts streamline the submission process, minimizing delays and expediting approvals. This agility can be the difference between seizing market opportunities and falling behind competitors.
Risk Mitigation: Regulatory experts identify potential compliance pitfalls and proactively address them, reducing the risk of costly setbacks or rejections. Their meticulous approach safeguards your investments.
Comprehensive Strategy: Crafting a comprehensive regulatory strategy is pivotal. Regulatory experts develop tailored roadmaps, optimizing your chances of successful submissions and market entry.
Resource Optimization: By entrusting regulatory matters to experts, you free your internal teams to focus on core competencies like research, development, and marketing. This resource allocation enhances overall productivity.
Quality Assurance: Ensuring the quality and safety of your pharmaceutical products is non-negotiable. Regulatory experts implement robust quality assurance measures to maintain product integrity.
Global Reach: If your aspirations extend beyond domestic markets, regulatory experts navigate the complexities of international submissions, making global expansion a reality.
Cost-Efficiency: While it may seem counterintuitive, hiring regulatory experts often leads to cost savings. Their proficiency minimizes the risk of costly mistakes or delays, ultimately optimizing your budget.
Reputation Protection: Regulatory compliance is integral to your brand’s reputation. By partnering with experts, you demonstrate a commitment to integrity and safety, bolstering your image in the industry.
Competitive Edge: In an increasingly competitive pharmaceutical landscape, timely approvals and market access are paramount. Regulatory experts give you a competitive edge by ensuring you’re at the forefront of industry advancements.
Our team of experts have licensed several different types of products, including disinfectants, cough & cold medication, allergy medication, sunscreens, and more! Some of these services include; NHP, medical devices, dietary supplements, and veterinary health products (VHP).
Our Canadian OTC Regulatory Experts are backed with extensive knowledge and years of experience. We offer OTC compliance consulting services for all types of companies to lessen the regulatory risk and assure a speedy way for the launch of your OTC drug. We also provide FDA Drug compliance solutions in the United States.
Former Health Canada officers will guide you on how to submit a meeting request, prepare for discussion as well as attend meetings with you to offer support with Health Canada officials.
Wondering how to get a Drug Establishment License? We offer complete support to register your facility for an Establishment License and ensure compliance with Good Manufacturing Practices (GMP). Contact us for more information.
Wondering how to get an Establishment License? We offer complete support to register your facility for an Establishment License along with annexing foreign sites to Canadian import license holders.
Worried about Plain Language Labelling (PLL) compliance and French Translation? Don't worry. We ensure your drug product label meets the applicable language requirements and follows the PLL format.
A Drug Identification Number (DIN Number) is a computer-generated eight-digit number assigned by Health Canada to a drug product prior to being marketed in Canada. It uniquely identifies all drug products sold in a dosage form in Canada and is located on the label of prescription and over-the-counter drug products that have been evaluated and authorized for sale in Canada. A DIN lets the user know that the product has undergone and passed a review of its formulation, labeling and instructions for use. A drug product sold in Canada without a DIN is not in compliance with Canadian law.
Through Health Canada’s Plain Language Labelling Initiative, there are new requirements for health product labelling and packaging, including a requirement for a Drug Facts Table (Facts Table) on the outer label of non-prescription drugs. The standardized format of the Drug Facts Table will help consumers find important product information quickly and easily.
Regulatory Considerations when Selling Foods and Beverages in the United States Selling food products in the United States requires compliance with various regulations to
... Read more
Health Canada 2024 Changes for Nicotine Replacement Therapies (NRT) On August 22, 2024, the Honourable Mark Holland, Minister of Health, announced new measures aimed at
... Read more
How to Create Health Canada Compliant Food Labels When entering the Canadian market, designing your food labels correctly is not just important—it’s critical. The Canadian
... Read more
The FDA has taken a significant step forward in its ongoing sodium reduction initiative by issuing new, voluntary sodium reduction targets in a draft guidance,
... Read morePlease complete the form below. We will respond to you soon.
